Have you lost money on your investment? Johnson Fistel, LLP encourages investors to contact the company


SAN DIEGO, December 5, 2021 / PRNewswire / –

Shareholder rights law firm Johnson Fistel, LLP, is investigating potential claims against the following companies for violating federal securities laws.

Summit Therapeutics Inc. (NASDAQ: SMMT)
LifeStance Health Group, Inc. (NASDAQ: LFST)
Berkeley Lights Inc. (NASDAQ: BLI)
Rollins, Inc. (NYSE: ROL)

The is not a cost or an obligation for you. If you would like to learn more about any of the following surveys, please contact the Senior Analyst Jim baker (jimb@johnsonfistel.com) at 619-814-4471. If you are sending an email, please include your phone number.

Summit Therapeutics Inc. (NASDAQ: SMMT)

In a file filed with the United States Securities and Exchange Commission on September 21, 2021, Summit disclosed that it “received comments from the United States Food and Drug Administration (the ‘FDA’) that the FDA did not agree with the change in the primary endpoint proposed by Summit and put subsequently implemented in its ongoing phase III Ri-CoDIFy. studies when combining studies.

[click here to join this action]

LifeStance Health Group, Inc. (NASDAQ: LFST)

At Wednesday August 11, 2021, LifeStance has released its second quarter ended June 30, 2021, financial results, showing a net loss of $ 70 million. Just two months ago, on or about June 10, 2021, LifeStance sold approximately 40 million shares as part of its initial public offering (the “IPO”) to $ 18 one hand, lifting close to $ 720 million in the new capital. Since the IPO, the stock has collapsed; to December 3, 2021, the action closed at $ 8.67.

Specifically, Johnson fistel investigation is to determine whether documents filed by the Company with the United States Securities and Exchange Commission in connection with its June 2021 The IPO and subsequent investor communications contained false statements of material fact or failed to state other facts necessary to ensure that the statements made therein were not misleading about the business and operations of the Company.

[Click here to join this action]

Berkeley Lights Inc. (NASDAQ: BLI)

At September 15, 2021, Scorpion Capital published a report on short sellers on Berkeley Lights. In the statement, Scorpion Capital alleged, among other things, that “a series of customers who claim to have been” cheated “, misled or over-promised by purchasing a $ 2 million lemon. The reality is so far removed from BLI’s awe-inspiring hype that we believe its product claims and practices may constitute outright fraud. among 14 of BLI’s biggest customers. We believe that the customers we spoke with represent over 30-50% of the overall installed base of BLI’s 92 cell screening systems. We believe our research may represent the most in-depth due diligence to date on BLI, leading us to conclude that this is just another vaporous venture capital IPO promotion with under value. -jacent zero. “

[Click here to join this action]

Rollins, Inc. (NYSE: ROL)

At October 28, 2020, Rollins filed its Form 10-Q with the Securities and Exchange Commission (“SEC”), disclosing an SEC investigation into how the company established period-end accruals and reserves and impact of these adjustments and reserves on declared profits for the periods beginning January 1, 2015. The Company’s Form 10-K 2020 later disclosed the results of an internal investigation initiated by the Company which revealed a material deficiency in the Company’s internal controls regarding the documentation and review of accounting entries for certain reserves. and accrued charges. Then on October 29, 2021Rollins said he has entered into discussions with SEC staff regarding a possible investigative resolution. It recorded a related provision during the third quarter of 2021, which is reflected in the financial statements of the Company.

[Click here to join this action]

On Johnson fistel, LLP:
Johnson fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, new York, and Georgia. The firm represents individual and institutional investors in class actions between shareholders and derivatives. For more information on the firm and its lawyers, visit http://www.johnsonfistel.com. Lawyer advertising. Past results do not guarantee future results.

Contact:
Johnson fistel, LLP
Jim baker, 619-814-4471
jimb@johnsonfistel.com

Cision

Show original content:https://www.prnewswire.com/news-releases/investigation-alert-did-you-lose-money-on-your-investment-johnson-fistel-llp-encourages-investors-to-contact-the-firm- 301437543.html

THE SOURCE Johnson fistel, LLP


Comments are closed.